RPL15 and leukemia: The first one refers to the pan-inhibitor of Aurora kinases danusertib, which has been shown to repress RPL15 signaling, notably negatively regulating the AURKB/p70S6K/RPL15 axis, and the effect leads to cell death (by apoptosis and autophagy) of human leukemia cells [48].